Avraham Raz
- Immunology top 0.1%
- Galectins and Cancer Biology 103
- Toxin Mechanisms and Immunotoxins 29
- Oncology top 0.5%
- Peptidase Inhibition and Analysis 28
- Molecular Biology top 0.5%
- Signaling Pathways in Disease 50
- Glycosylation and Glycoproteins Research 37
- Cancer Research top 0.5%
- Immunology and Allergy top 0.5%
-
- Erythrocyte Function and Pathophysiology 26
-
- Cellular Mechanics and Interactions 18
-
- Monoclonal and Polyclonal Antibodies Research 18
- Co-authors
- Victor HoganPratima Nangia‐MakkerHidenori InoharaTomoharu FukumoriReuben LotanYukinori TakenakaTatsuyoshi FunasakaIvan R. Nabi
- Cited by
- ImmunologyOncologyMolecular Biology
- Journals
- Cancer Research (27 papers)International Journal of Cancer (18 papers)Journal of Biological Chemistry (11 papers)
- Partner nations
- United StatesJapanIsrael
In The Last Decade
Avraham Raz
224 papers receiving 14.9k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Immunology 7.6k
- Oncology 3.9k
- Molecular Biology 9.4k
- Cancer Research 1.8k
- Immunology and Allergy 637
Countries citing papers authored by Avraham Raz
This map shows the geographic impact of Avraham Raz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avraham Raz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avraham Raz more than expected).
Fields of papers citing papers by Avraham Raz
This network shows the impact of papers produced by Avraham Raz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avraham Raz. The network helps show where Avraham Raz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Avraham Raz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 18 | |
| 2 | 2021 | 39 | |
| 3 | 2016 | 53 | |
| 4 | 2013 | 37 | |
| 5 | 2012 | 81 | |
| 6 | 2009 | 69 | |
| 7 | 2008 | 49 | |
| 8 | 2007 | 31 | |
| 9 | 2007 | 57 | |
| 10 | 2007 | 0 | |
| 11 | Inhibition of breast cancer progression by a medicinal herb Ocimum sanctum | 2006 | 2 |
| 12 | 2005 | 39 | |
| 13 | Inhibition of angiogenesis by a common herb: Ocimum sactum | 2004 | 1 |
| 14 | 2004 | 2 | |
| 15 | Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. | 2003 | 75 |
| 16 | Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors. | 2002 | 18 |
| 17 | 1997 | 27 | |
| 18 | Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. | 1996 | 235 |
| 19 | Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3. | 1996 | 91 |
| 20 | Colon cancer mucin | 1996 | 2 |
About Avraham Raz
Avraham Raz is a scholar working on Immunology, Immunology and Allergy, Molecular Biology, Cell Biology and Oncology, having authored 228 papers that have together received 15.2k indexed citations. Recurring topics across this work include Galectins and Cancer Biology (103 papers), Signaling Pathways in Disease (50 papers), Glycosylation and Glycoproteins Research (37 papers), Toxin Mechanisms and Immunotoxins (29 papers), Peptidase Inhibition and Analysis (28 papers), Erythrocyte Function and Pathophysiology (26 papers), Cellular Mechanics and Interactions (18 papers) and Monoclonal and Polyclonal Antibodies Research (18 papers). The work is most often cited by research in Immunology (7.6k citations), Oncology (3.9k citations), Molecular Biology (9.4k citations), Cancer Research (1.8k citations) and Immunology and Allergy (637 citations). Avraham Raz has collaborated with scholars based in United States, Japan and Israel. Frequent co-authors include Victor Hogan, Pratima Nangia‐Makker, Hidenori Inohara, Tomoharu Fukumori, Reuben Lotan, Yukinori Takenaka, Tatsuyoshi Funasaka, Ivan R. Nabi, Shiro Akahani and Isaiah J. Fidler. Their work appears in journals such as Cancer Research, International Journal of Cancer, Journal of Biological Chemistry, Cancer and Metastasis Reviews and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.